We are live on ! Find out more
INVA icon

Innoviva

234 hedge funds and large institutions have $1.13B invested in Innoviva in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 84 increasing their positions, 76 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more call options, than puts

Call options by funds: $12.4M | Put options by funds: $4.23M

11% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 76

6% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 36

0% more funds holding

Funds holding: 233234 (+1)

0.41% more ownership

Funds ownership: 79.22%79.63% (+0.41%)

18% less capital invested

Capital invested by funds: $1.38B → $1.13B (-$245M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
234
Holders Change
+1
Holders Change %
+0.43%
% of All Funds
5.06%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
38
Increased
84
Reduced
76
Closed
36
Calls
$12.4M
Puts
$4.23M
Net Calls
+$8.16M
Net Calls Change
-$16.9M

INVA Hedge Fund Activity: Q1 2019 in Review

234 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q1 2019, worth a combined $1.13B — down 18% from $1.38B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new INVA positions and 36 closed out — a net gain of 2 holders — while 84 added to existing stakes and 76 trimmed.

The largest buyer was Sarissa Capital Management, adding an estimated $15.8M. The largest seller was Deutsche Bank, cutting an estimated $10.9M.

  • 234 institutional investors held Innoviva (INVA) as of Q1 2019, up from 233 in Q4 2018.
  • Funds reported $1.13B of Innoviva stock for Q1 2019, down 18% quarter-over-quarter.
  • 38 funds opened new Innoviva positions in Q1 2019 and 36 closed out, a net change of +2 holders.
  • The largest Innoviva buyer in Q1 2019 was Sarissa Capital Management, an estimated $15.8M added.
  • The largest Innoviva seller in Q1 2019 was Deutsche Bank, an estimated $10.9M sold.

Based on aggregated 13F filings for Q1 2019.